Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
You can explore more antioxidant products featuring vitamin C for brighter skin routines
The tinted face and body moisturizer hydrates the skin and leaves behind a subtle tint of color with a luminous, glowy finishas if youve just come off a seriously relaxing tropical vacation
Read clinical review Comparisons BPC-157 Compounding Pharmacy: Research-Only vs Medical-Grade Peptides Explained A physician-reviewed guide to BPC-157 sourcing: how research-grade and compounded medical-grade peptides differ by regulation, purity testing, and legal status in 2024
Did taking a probiotic further reduce symptoms of irritable bowel syndrome in people on a low-FODMAP diet
View Record Details Media by Ryan Douglas